Vitalhub (TSE:VHI) Given a C$14.00 Price Target at Scotiabank

Vitalhub (TSE:VHI) received a C$14.00 price target from equities research analysts at Scotiabank in a research note issued to investors on Thursday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Scotiabank’s target price points to a potential upside of 19.25% from the stock’s current price.

A number of other research firms also recently weighed in on VHI. Cormark upped their target price on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd. Canaccord Genuity Group lifted their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a report on Thursday, January 16th. Finally, TD Securities raised Vitalhub to a “strong-buy” rating in a research report on Monday, November 25th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average target price of C$10.71.

Vitalhub Trading Up 2.3 %

Shares of VHI traded up C$0.26 during mid-day trading on Thursday, reaching C$11.74. The company’s stock had a trading volume of 60,649 shares, compared to its average volume of 125,785. Vitalhub has a 52 week low of C$4.36 and a 52 week high of C$12.09. The stock has a market cap of C$596.98 million, a PE ratio of 106.73, a P/E/G ratio of 1.18 and a beta of 1.26. The company’s fifty day moving average price is C$11.26 and its two-hundred day moving average price is C$9.63.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.